Antithrombotic therapy for the prevention of reinfarction after reperfusion therapy: the price of success.
Gulati
Rajiv
R
Gersh
Bernard J
BJ
D002681:China; D002986:Clinical Trials as Topic; D000077144:Clopidogrel; D004562:Electrocardiography; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D015424:Reperfusion / Q000009:adverse effects*; D055502:Secondary Prevention; D015912:Thrombolytic Therapy; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D000077144:Clopidogrel; D013988:Ticlopidine